| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |